A symposium exploring how modern CT and AI technologies can help address these challenges across the lung cancer screening pathway – from image acquisition and reconstruction to analysis, reporting, and follow-up.
Across Europe, lung cancer screening (LCS) with low-dose CT is progressively expanding. As national programs are implemented and European initiatives support wider adoption, important challenges – such as ensuring diagnostic confidence at low dose, improving accessibility, supporting efficient workflows, and managing nodules and incidental findings – remain.
Symposium recording from ESTI 2026
Course Information
At the end of this lecture, delegates will:
- Learn how CT and AI can help improve accessibility and efficiency in LCS through faster workflows in image acquisition, analysis and reporting
- Discover the latest dose reduction technologies in CT, at both the hardware and software levels
- Learn how AI in image reconstruction and analysis can help in the management of nodules and incidental findings
Disclaimer: Appearing on the Canon Medical Academy does not represent a commercial partnership or interest from the speaker. The views herein do not represent the views of Canon Medical Systems Ltd.



Text-to-speech